CAREMARK ULYSSES HOLDING CORP.

Caremark Ulysses Holding Corp. provides comprehensive pharmacy benefit management and related administrative services to hospital and medical service plans, operating within SIC 6324’s managed-care universe where payers expect integrated pharmacy, specialty, and utilization-review capabilities. Serving employers, union trusts, and federal and state health programs, the company stitches together networks meant to keep medication fulfillment, formulary design, and rebate capture aligned with inpatient and outpatient provider systems. Material risks revolve around tight federal and state reimbursement rules, antitrust scrutiny over network consolidation, and the compliance burden of HIPAA and CMS audits that can affect enrollment, pricing, and cash flow. With no ticker, stakeholders rely on disclosure governance to understand how the company balances negotiated drug costs with the long-term incentives of hospitals, physicians, and beneficiaries, a narrative reflected in the most recent Form 10-Q filed Nov 1999. CIK 709878 anchors the historical record and reminds readers to view live SEC filings on Earnings Feed.

Source: Earnings Feed research · last updated 11/24/2025